| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding the oxygen carrier M101 to a cold-storage solution could be an alternative to HOPE for liver graft preservation
|
Alix, Pierre
|
|
|
|
4 |
p.
|
artikel
|
| 2 |
Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study
|
Jung, Young Mi
|
|
|
|
4 |
p.
|
artikel
|
| 3 |
A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients
|
Nachit, Maxime
|
|
|
|
4 |
p.
|
artikel
|
| 4 |
AlcoChange: A digital therapeutic for patients with alcohol-related liver disease
|
Mehta, Gautam
|
|
|
|
4 |
p.
|
artikel
|
| 5 |
A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals
|
Yang, Jaewon
|
|
|
|
4 |
p.
|
artikel
|
| 6 |
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
|
Boudewijns, Robbert
|
|
|
|
4 |
p.
|
artikel
|
| 7 |
A personalized approach for tumour biopsy in hepatocellular carcinoma
|
Ronot, Maxime
|
|
|
|
4 |
p.
|
artikel
|
| 8 |
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma
|
Santoro, Armando
|
|
|
|
4 |
p.
|
artikel
|
| 9 |
A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
|
Nevens, Frederik
|
|
|
|
4 |
p.
|
artikel
|
| 10 |
Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?
|
Espinós, Carmen
|
|
|
|
4 |
p.
|
artikel
|
| 11 |
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction
|
Nam, David
|
|
|
|
4 |
p.
|
artikel
|
| 12 |
A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
|
Azoulay, Daniel
|
|
|
|
4 |
p.
|
artikel
|
| 13 |
Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
|
Arvaniti, Pinelopi
|
|
|
|
4 |
p.
|
artikel
|
| 14 |
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis
|
Zermatten, Maxime G.
|
|
|
|
4 |
p.
|
artikel
|
| 15 |
Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice
|
Zhai, Tingting
|
|
|
|
4 |
p.
|
artikel
|
| 16 |
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
|
Kurosaki, Shigeyuki
|
|
|
|
4 |
p.
|
artikel
|
| 17 |
Cellular origins of regenerating liver and hepatocellular carcinoma
|
Holczbauer, Ágnes
|
|
|
|
4 |
p.
|
artikel
|
| 18 |
Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?
|
Izzy, Manhal
|
|
|
|
4 |
p.
|
artikel
|
| 19 |
Comment on “Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse”
|
Shahid, Nayab
|
|
|
|
4 |
p.
|
artikel
|
| 20 |
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents
|
Ezaizi, Yamen
|
|
|
|
4 |
p. 259-264
|
artikel
|
| 21 |
Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C
|
Rao, Huiying
|
|
|
|
4 |
p.
|
artikel
|
| 22 |
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
|
Kim, Bo Hyun
|
|
|
|
4 |
p.
|
artikel
|
| 23 |
Contents
|
|
|
|
|
4 |
p.
|
artikel
|
| 24 |
Contents
|
|
|
|
|
4 |
p. iii
|
artikel
|
| 25 |
Contents
|
|
|
|
|
4 |
p.
|
artikel
|
| 26 |
Contents
|
|
|
|
|
4 |
p.
|
artikel
|
| 27 |
Contents
|
|
|
|
|
4 |
p.
|
artikel
|
| 28 |
Contents
|
|
|
|
|
4 |
p.
|
artikel
|
| 29 |
Copyright and information
|
|
|
|
|
4 |
p.
|
artikel
|
| 30 |
Copyright and information
|
|
|
|
|
4 |
p. e1
|
artikel
|
| 31 |
Copyright and information
|
|
|
|
|
4 |
p.
|
artikel
|
| 32 |
Copyright and information
|
|
|
|
|
4 |
p.
|
artikel
|
| 33 |
Copyright and information
|
|
|
|
|
4 |
p.
|
artikel
|
| 34 |
Copyright and information
|
|
|
|
|
4 |
p.
|
artikel
|
| 35 |
Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
|
Erhardtsen, Elisabeth
|
|
|
|
4 |
p.
|
artikel
|
| 36 |
Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites
|
Bossen, Lars
|
|
|
|
4 |
p. 265-269
|
artikel
|
| 37 |
Does ammonia really disrupt brain oxygen homeostasis?
|
Sørensen, Michael
|
|
|
|
4 |
p.
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
4 |
p. i
|
artikel
|
| 39 |
Editorial Board
|
|
|
|
|
4 |
p.
|
artikel
|
| 40 |
Editorial Board page
|
|
|
|
|
4 |
p.
|
artikel
|
| 41 |
Editorial Board page
|
|
|
|
|
4 |
p.
|
artikel
|
| 42 |
Editorial Board page
|
|
|
|
|
4 |
p.
|
artikel
|
| 43 |
Editorial Board page
|
|
|
|
|
4 |
p.
|
artikel
|
| 44 |
Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial
|
Brown, Elizabeth A.
|
|
|
|
4 |
p.
|
artikel
|
| 45 |
Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure
|
Fernández, Javier
|
|
|
|
4 |
p.
|
artikel
|
| 46 |
Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
|
Kaur, Savneet
|
|
|
|
4 |
p.
|
artikel
|
| 47 |
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
|
Gairing, Simon Johannes
|
|
|
|
4 |
p.
|
artikel
|
| 48 |
Embedding assessment of liver fibrosis into routine diabetic review in primary care
|
Mansour, Dina
|
|
|
|
4 |
p.
|
artikel
|
| 49 |
Environmental exposures are important risk factors for advanced liver fibrosis in African American adults
|
Ma, Ning
|
|
|
|
4 |
p.
|
artikel
|
| 50 |
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
|
Younossi, Zobair M.
|
|
|
|
4 |
p.
|
artikel
|
| 51 |
Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
|
Meijnikman, Abraham Stijn
|
|
|
|
4 |
p.
|
artikel
|
| 52 |
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
|
Poynard, Thierry
|
|
|
|
4 |
p.
|
artikel
|
| 53 |
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
|
Gastaldelli, Amalia
|
|
|
|
4 |
p. 312-328
|
artikel
|
| 54 |
Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study
|
Zheng, Melanie
|
|
|
|
4 |
p.
|
artikel
|
| 55 |
Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly
|
Danpanichkul, Pojsakorn
|
|
|
|
4 |
p.
|
artikel
|
| 56 |
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
|
D’Amico, Federica
|
|
|
|
4 |
p.
|
artikel
|
| 57 |
HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?
|
Costentin, Charlotte E.
|
|
|
|
4 |
p.
|
artikel
|
| 58 |
Hepatic microbiome in healthy lean and obese humans
|
Suppli, Malte Palm
|
|
|
|
4 |
p.
|
artikel
|
| 59 |
Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2
|
Liang, Yaojie
|
|
|
|
4 |
p.
|
artikel
|
| 60 |
Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency
|
Karatas, Esra
|
|
|
|
4 |
p.
|
artikel
|
| 61 |
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
|
Schmalz, Franziska
|
|
|
|
4 |
p.
|
artikel
|
| 62 |
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma
|
Yang, Hannah
|
|
|
|
4 |
p.
|
artikel
|
| 63 |
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
|
Laschtowitz, Alena
|
|
|
|
4 |
p.
|
artikel
|
| 64 |
Human hepatitis D virus-specific T cell epitopes
|
Kohsar, Matin
|
|
|
|
4 |
p.
|
artikel
|
| 65 |
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency
|
Li, Chao Zheng
|
|
|
|
4 |
p.
|
artikel
|
| 66 |
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
|
Healy, Katie
|
|
|
|
4 |
p.
|
artikel
|
| 67 |
IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer
|
de Vries, Elsemieke
|
|
|
|
4 |
p.
|
artikel
|
| 68 |
Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD
|
Diniz, Ariane Barros
|
|
|
|
4 |
p.
|
artikel
|
| 69 |
Immunobiology of cholangiocarcinoma
|
Loeuillard, Emilien
|
|
|
|
4 |
p. 297-311
|
artikel
|
| 70 |
Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH
|
Anstee, Quentin M.
|
|
|
|
4 |
p.
|
artikel
|
| 71 |
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
|
Balcar, Lorenz
|
|
|
|
4 |
p.
|
artikel
|
| 72 |
Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis
|
Rashidi-Alavijeh, Jassin
|
|
|
|
4 |
p.
|
artikel
|
| 73 |
Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease
|
Johansen, Stine
|
|
|
|
4 |
p.
|
artikel
|
| 74 |
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
|
Aggarwal, Abhishek
|
|
|
|
4 |
p.
|
artikel
|
| 75 |
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component
|
Su, Jinpeng
|
|
|
|
4 |
p.
|
artikel
|
| 76 |
JHEP Reports: The fourth issue
|
Gustot, Thierry
|
|
|
|
4 |
p. 257-258
|
artikel
|
| 77 |
Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection
|
Trampert, David C.
|
|
|
|
4 |
p.
|
artikel
|
| 78 |
Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis
|
Oo, Ye Htun
|
|
|
|
4 |
p. 286-296
|
artikel
|
| 79 |
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
|
Yuen, Man-Fung
|
|
|
|
4 |
p.
|
artikel
|
| 80 |
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas
|
Chopinet, Sophie
|
|
|
|
4 |
p.
|
artikel
|
| 81 |
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
|
Pastore, Mirella
|
|
|
|
4 |
p.
|
artikel
|
| 82 |
Management of splanchnic vein thrombosis
|
Elkrief, Laure
|
|
|
|
4 |
p.
|
artikel
|
| 83 |
Mechanistic insights into the inhibition of NTCP by myrcludex B
|
Donkers, Joanne M.
|
|
|
|
4 |
p. 278-285
|
artikel
|
| 84 |
Natural antibodies are required for clearance of necrotic cells and recovery from acute liver injury
|
Mattos, Matheus Silvério
|
|
|
|
4 |
p.
|
artikel
|
| 85 |
New frontiers in liver resection for hepatocellular carcinoma
|
Allaire, Manon
|
|
|
|
4 |
p.
|
artikel
|
| 86 |
Non-alcoholic fatty liver disease in lean individuals
|
Albhaisi, Somaya
|
|
|
|
4 |
p. 329-341
|
artikel
|
| 87 |
Novel vectors and approaches for gene therapy in liver diseases
|
Maestro, Sheila
|
|
|
|
4 |
p.
|
artikel
|
| 88 |
Operating under pressure: Is there a place for preoperative TIPS?
|
Praktiknjo, Michael
|
|
|
|
4 |
p.
|
artikel
|
| 89 |
Platelet-derived thrombospondin 1 promotes immune cell liver infiltration and exacerbates diet-induced steatohepatitis
|
Gwag, Taesik
|
|
|
|
4 |
p.
|
artikel
|
| 90 |
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
|
Iwakiri, Yasuko
|
|
|
|
4 |
p.
|
artikel
|
| 91 |
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
|
Zaccherini, Giacomo
|
|
|
|
4 |
p. 270-277
|
artikel
|
| 92 |
Predictive value of platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio in HCC treated with sorafenib and radioembolization
|
Öcal, Osman
|
|
|
|
4 |
p.
|
artikel
|
| 93 |
Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
|
Yamashita, Yuki
|
|
|
|
4 |
p.
|
artikel
|
| 94 |
Protective potential of the gallbladder in primary sclerosing cholangitis
|
Cazzagon, Nora
|
|
|
|
4 |
p.
|
artikel
|
| 95 |
Quality and reproducibility during the COVID-19 pandemic
|
Gustot, Thierry
|
|
|
|
4 |
p.
|
artikel
|
| 96 |
Reply to: “Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?”
|
Allaire, Manon
|
|
|
|
4 |
p.
|
artikel
|
| 97 |
Reply to: “Comment on ”
|
Donnadieu, Hélène
|
|
|
|
4 |
p.
|
artikel
|
| 98 |
Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice
|
Seedorf, Klaus
|
|
|
|
4 |
p.
|
artikel
|
| 99 |
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
|
Schulte, Lucas A.
|
|
|
|
4 |
p.
|
artikel
|
| 100 |
Should we use liver grafts repeatedly refused by other transplant teams?
|
Winter, Audrey
|
|
|
|
4 |
p.
|
artikel
|
| 101 |
Small molecule drugs promote repopulation of transplanted hepatocytes by stimulating cell dedifferentiation
|
Jiang, Mengmeng
|
|
|
|
4 |
p.
|
artikel
|
| 102 |
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
|
Giersch, Katja
|
|
|
|
4 |
p.
|
artikel
|
| 103 |
Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferation
|
Bardeck, Nils
|
|
|
|
4 |
p.
|
artikel
|
| 104 |
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
|
Féray, Cyrille
|
|
|
|
4 |
p.
|
artikel
|
| 105 |
Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B
|
van Buuren, Nicholas
|
|
|
|
4 |
p.
|
artikel
|
| 106 |
The liver matrisome – looking beyond collagens
|
Arteel, Gavin E.
|
|
|
|
4 |
p.
|
artikel
|
| 107 |
Time to broaden the screening strategy for chronic hepatitis B virus infection beyond the emergency department
|
Kalo, Eric
|
|
|
|
4 |
p.
|
artikel
|
| 108 |
Transcriptomic landscapes of effective and failed liver regeneration in humans
|
Starlinger, Patrick
|
|
|
|
4 |
p.
|
artikel
|
| 109 |
Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
|
Dietz-Fricke, Christopher
|
|
|
|
4 |
p.
|
artikel
|
| 110 |
Tumour cell-expressed PD-L1 reprograms lipid metabolism via EGFR/ITGB4/SREBP1c signalling in liver cancer
|
Zhao, Man
|
|
|
|
4 |
p.
|
artikel
|
| 111 |
Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis
|
Zhou, Hua
|
|
|
|
4 |
p.
|
artikel
|
| 112 |
Using cell-free DNA for HCC surveillance and prognosis
|
Tran, Nguyen H.
|
|
|
|
4 |
p.
|
artikel
|
| 113 |
Where does TIPS fit in the management of patients with cirrhosis?
|
García-Pagán, Juan Carlos
|
|
|
|
4 |
p.
|
artikel
|
Tijdschrift beschrijving